Research Article
The Alteration and Clinical Significance of Th22/Th17/Th1 Cells in Patients with Chronic Myeloid Leukemia
Table 1
The characteristics of subjects.
| | | ND CML | CP-CML | Healthy control | | | () | () | () |
| | Age (years) | 48.25 ± 14.99 | 46.22 ± 13.73 | 37.00 ± 10.28 | | Gender (male/female) | 18/13 | 19/13 | 20/13 | | WBC (109/L) | 189.74 ± 116.37 | 6.10 ± 1.69 | 6.37 ± 2.52 | | HB (g/L) | 103.93 ± 24.26 | 134.33 ± 17.55 | 128.25 ± 14.35 | | PLT (109/L) | 505.12 ± 323.68 | 209.16 ± 91.25 | 215.25 ± 115.64 | | BCR-ABL (%) IS | 61.16 (27.51–183.9) | 0.056 (0.000–28.85) | |
|
|
ND: newly diagnosed; CP-CML: chronic phase-CML; WBC: white blood cell; RBC: red blood cell; HB: hemoglobin; PLT: platelet.
|
